ARES CAPITAL CORP

Rule 10b5-1 Trading Plans

During the fiscal quarter ended June 30, 2024, none of our directors or executive officers adopted orterminated any contract, instruction or written plan for the purchase or sale of our securities to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”

Amendment to BNP Funding Facility

On July 25, 2024, we and our consolidated subsidiary, AFB, amended the BNP Funding by entering into BNP Amendment No. 8. The BNP Amendment No. 8, among other things, (a) increased the total commitment under the BNP Funding Facility from $865 million to $1,265 million, (b) extended the end of the reinvestment period from April 20, 2026 to July 26, 2027, (c) extended the stated maturity date from April 20, 2028 to July 26, 2029 and (d) adjusted the interest rate charged on the BNP Funding Facility from an applicable SOFR or a “base rate” (as defined in the document governing the BNP Funding Facility) plus a margin of (i) 2.50% during the reinvestment period and (ii) 3.00% following the reinvestment period to an applicable SOFR or a “base rate” plus a margin of (i) 2.10% during the reinvestment period and (ii) 2.60% following the reinvestment period. The other terms of the BNP Funding Facility remained materially unchanged. The foregoing description of BNP Amendment No. 8 is only a summary of the material provisions of BNP Amendment No. 8 and is qualified in its entirety by reference to a copy of such amendment, which is filed herewith as Exhibit 10.6, and by this reference incorporated herein.